![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Cardiovascular Biology Research Group, Department of Pharmacology, Yong Loo Lin School of Medicine, Singapore, Singapore (J.-S.B., Q.C.Y., T.-T.P., Z.-N.F., M.Y.A., P.K.M.); and Department of Pharmacy, Faculty of Science, National University of Singapore (S.Z.), Singapore, Singapore
Endogenous H2S is synthesized mainly by cystathionine
-lyase in the heart. The present study investigated the role of H2S in cardioprotection induced by ischemic preconditioning. We have examined the effect of endogenous H2S and exogenous application of NaHS (H2S donor) on cardiac rhythm in the isolated rat heart subjected to low-flow ischemia insults as well as cell viability and function in isolated myocytes exposed to simulated ischemia solution. Preconditioning with NaHS (SP) or ischemia (IP) for three cycles (3 min each cycle separated by 5 min of recovery) significantly decreased the duration and severity of ischemia/reperfusion-induced arrhythmias in the isolated heart while increasing cell viability and the amplitude of electrically induced calcium transients after ischemia/reperfusion in cardiac myocytes. Both IP and SP also significantly attenuated the decreased H2S production during ischemia. Moreover, decreasing endogenous H2S production significantly attenuated the protective effect of IP in both the isolated heart and isolated cardiac myocytes. Blockade of protein kinase C with chelerythrine or bisindolylmaleimide I as well as ATP-sensitive K+ (KATP) channel with glibenclamide (a nonselective KATP blocker) and HMR-1098 (1-[[5-[2-(5-Chloro-o-anisamido)ethyl]-2-methoxyphenyl]sulfonyl]-3-methylthiourea) (a sarcolemmal KATP channel blocker) reversed the cardioprotection induced by SP or IP. However, blockade of mitochondrial KATP channels with 5-hydroxydecanoic acid had no effect on the cardioprotection of SP, suggesting that, unlike the mechanism involved in IP, mitochondrial KATP channels most probably do not play a major role in the cardioprotection of SP. Our findings suggest that endogenous H2S contributes to cardioprotection induced by IP, which effect may involve protein kinase C and sarcolemmal KATP channels.
Address correspondence to: Dr. Jin-Song Bian, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore. E-mail: phcbjs{at}nus.edu.sg
This article has been cited by other articles:
![]() |
M. Yusof, K. Kamada, T. Kalogeris, F. S. Gaskin, and R. J. Korthuis Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H868 - H876. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. C. Yong, S. W. Lee, C. S. Foo, K. L. Neo, X. Chen, and J.-S. Bian Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1330 - H1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Sun, Y.-X. Cao, W.-W. Wang, S.-F. Ma, T. Yao, and Y.-C. Zhu Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes Cardiovasc Res, September 1, 2008; 79(4): 632 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bliksoen, M.-L. Kaljusto, J. Vaage, and K.-O. Stenslokken Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 344 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jha, J. W. Calvert, M. R. Duranski, A. Ramachandran, and D. J. Lefer Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H801 - H806. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-T. Pan, K. L. Neo, L.-F. Hu, Q. C. Yong, and J.-S. Bian H2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes Am J Physiol Cell Physiol, January 1, 2008; 294(1): C169 - C177. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Miller and M. B. Roth Hydrogen sulfide increases thermotolerance and lifespan in Caenorhabditis elegans PNAS, December 18, 2007; 104(51): 20618 - 20622. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lefer A new gaseous signaling molecule emerges: Cardioprotective role of hydrogen sulfide PNAS, November 13, 2007; 104(46): 17907 - 17908. [Full Text] [PDF] |
||||
![]() |
B. Geng, Y. Cui, J. Zhao, F. Yu, Y. Zhu, G. Xu, Z. Zhang, C. Tang, and J. Du Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1608 - R1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. Cai, M.-J. Wang, P. K. Moore, H.-M. Jin, T. Yao, and Y.-C. Zhu The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation Cardiovasc Res, October 1, 2007; 76(1): 29 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Storey and J. M. Storey Tribute to P. L. Lutz: putting life on `pause' - molecular regulation of hypometabolism J. Exp. Biol., May 15, 2007; 210(10): 1700 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhi, A. D. Ang, H. Zhang, P. K. Moore, and M. Bhatia Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-{kappa}B pathway J. Leukoc. Biol., May 1, 2007; 81(5): 1322 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Baskar, L. Li, and P. K. Moore Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells FASEB J, January 1, 2007; 21(1): 247 - 255. [Abstract] [Full Text] [PDF] |
||||